Related Experiment Video
Updated: Sep 23, 2025

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA
Chao Li1, Jingwen Wang2, Jun Feng3
1Department of Cardiology, Hefei Hospital Affiliated to Medical University of Anhui (the Second People's Hospital of Hefei), Hefei, 230011, Anhui, China.
Insights
Circular RNA of Toll-like receptor 4 (circ-TLR4) promotes cardiac hypertrophy by stabilizing its messenger RNA. This finding reveals a novel mechanism in cardiovascular disease development.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- RNA Biology
Background:
- Cardiac hypertrophy is a compensatory response to stress, but its dysregulation contributes to cardiovascular disease.
- Circular RNAs (circRNAs) play roles in cardiovascular diseases, including cardiac hypertrophy.
- Toll-like receptor 4 (TLR4) is implicated in inflammation and cardiac hypertrophy, but its circular isoforms are unstudied.
Purpose of the Study:
- To investigate the role of circ-TLR4 in cardiac hypertrophy.
- To elucidate the molecular mechanism by which circ-TLR4 influences cardiac hypertrophy.
Main Methods:
- RT-qPCR to measure circ-TLR4 and TLR4 expression in cardiomyocytes.
- Immunofluorescence and western blot to assess cardiac hypertrophy markers (cell surface area, ANF, BNP, β-MHC).
- RIP assay to confirm the interaction between circ-TLR4 and TLR4.
Main Results:
- Circ-TLR4 and TLR4 expression increased in cardiac hypertrophy models.
- Knockdown of circ-TLR4 reduced angiotensin II-induced hypertrophy.
- Circ-TLR4 stabilizes TLR4 mRNA by recruiting FUS.
- TLR4 overexpression reversed the effects of circ-TLR4 silencing.
Conclusions:
- Circ-TLR4 promotes cardiac hypertrophy.
- The mechanism involves FUS-mediated stabilization of TLR4 mRNA.
- Circ-TLR4 is a potential therapeutic target for cardiac hypertrophy.
Background:
Cardiac hypertrophy is an adaptive and compensatory mechanism preserving cardiac output during detrimental stimuli. Circular RNAs (circRNAs) have been illustrated to exert important implications in the pathogenesis of multiple cardiovascular diseases (CVD) including demonstrated cardiac hypertrophy. Toll-like receptor 4 (TLR4) has been previously reported to be a crucial regulator in inflammatory response and cardiac hypertrophy. However, the role of circular isoforms derived from TLR4 in cardiac hypertrophy remains unclear.
Methods:
Expression of circ-TLR4 and TLR4 in cardiomyocytes was detected by RT-qPCR. The indicators of cardiac hypertrophy responses, including cell surface area, atrial natriuretic factor (ANF), B-type natriuretic peptide (BNP) and β-myosin heavy chain (β-MHC) were measured by immunofluorescence staining and western blot. RIP assay was used to validate the interaction between circ-TLR4 and TLR4.
Results:
Circ-TLR4 and TLR4 was up-regulated in cellular models of cardiac hypertrophy. Circ-TLR4 knockdown attenuated angiotensin II (Ang II)-induced hypertrophy responses in cardiomyocytes. Moreover, circ-TLR4 positively regulated TLR4 expression through recruiting FUS to stabilize TLR4 mRNA. Furthermore, TLR4 overexpression rescued the cardiac responses mediated by circ-TLR4 silencing.
Conclusion:
Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

